Skip to search.
 TSX Down 0.42% TSX Ventures Down 1.40%

Geron Corporation (GERN)

-NasdaqGS
2.26 Up 0.05(2.26%) 4:00PM EDT
|After Hours : 2.26 0.00 (0.00%) 5:58PM EDT
Prev Close:2.21
Open:2.23
Bid:2.22 x 200
Ask:2.24 x 200
1y Target Est:4.38
Beta:3.76153
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:2.20 - 2.28
52wk Range:1.84 - 5.30
Volume:1,338,059
Avg Vol (3m):1,824,560
Market Cap:359.65M
P/E (ttm):282.50
EPS (ttm):0.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNUp 2.26%359.65M
BMYUp 0.47%93.13B
GSKUp 0.84%105.29B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.62
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.23
Quarterly EPS Est (Sep-16) :-0.06
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-1.93

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback